home / stock / nvo / nvo articles

NVO Articles, Novo Nordisk A/S - From 02/20/24

Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...
Ozempic Effect: Food Industry Feels The Heat As Weight-Loss Drugs Get Popular, Investors Call For Menu Makeovers | Benzinga

The rising popularity of weight-loss drugs like Ozempic is now pressuring food companies to reevaluate their business strategies. According to a re...
UK Becomes First Major Market for Eli Lilly's Mounjaro Prefilled Pen For Tackling Obesity | Benzinga

Pharmaceutical giant Eli Lilly And Co (NYSE:LLY) is set to launch its highly-anticipated obesity drug, Mounjaro (tirzepatide), in Britain...

What's Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk's Weight Loss Drug Wegovy | Benzinga

A growing number of U.S. adolescents, facing record rates of pediatric obesity, are reportedly turning to Novo Nordisk A/S’s (NYSE:...

Novo Nordisk's Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement | Benzinga

Preliminary findings presented at an orthopedic surgeons’ meeting on Monday indicate that new drugs designed for diabetes and weight loss cou...
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs | Benzinga

The unprecedented demand for weight loss drugs, including Novo Nordisk A/S’s (NYSE:NVO) Wegovy and Eli Lilly And Co’s&nb...

Ozempic Maker's Parent Company To Invest $7B Annually By 2030: 'We Have More Money Than Ever To Invest' | Benzinga

Novo Holdings, the major shareholder of Danish pharmaceutical company Novo Nordisk (NYSE:NVO), plans to ramp up its annual investments to $7 billio...

What's Going On Eli Lilly Stock Thursday? | Benzinga

Since Monday, Eli Lilly And Co (NYSE:LLY) shares have gained 8%, closing at $724.85 on Wednesday, sending the market capitalization to a ...
Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns | Benzinga

Novo Nordisk A/S (NYSE:NVO) has encountered manufacturing challenges and drug shortages for its diabetes and weight loss drugs due to unpreced...

What's Going On With Eli Lilly Stock Today? | Benzinga

Eli Lilly And Co’s (NYSE:LLY) shares are trading higher with a session volume of 1.683 million versus an average volume of 3.12 million,...

Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand | Benzinga

Maker of ‘miracle’ weight loss drugs Ozempic and Wegovy, Novo Nordisk A/S (NYSE:NVO) has announced the acquisition of three fill-finish...
Previous 10 Next 10